Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 734-739

  Talan, David A ^a   Klimberg, Ira W ^b   Nicolle, Lindsay E ^c   Song, James ^d   Kowalsky, Steven F ^d   Church, Deborah A ^d  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b Florida Found for Hlthcare Res   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d BAYER CORPORATION   (United States)

Author keywords

Ciprofloxacin; Kidney; Pyelonephritis; Urinary tract; Urinary tract infections

Indexed keywords

CIPROFLOXACIN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; ERADICATION THERAPY; ESCHERICHIA COLI; EXTENDED DRUG RELEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VOMITING;

EID: 0346499059     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000106191.11936.64     Document Type: Article

References (20)

1. Ronald, A.: The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med, suppl., 113: 14S, 2002
2. Stamm, W. E. and Hooton, T. M.: Management of urinary tract infections in adults. N Engl J Med, 329: 1328, 1993
3. Gorbach, S., Bartlett, J., Falagas, M. and Hamer, D.: Infectious diseases in clinical practice. In: 1999 Guidelines for Infectious Diseases in Primary Care. Baltimore: Lippincott Williams & Wilkins, pp. 68-69, 1998
4. Nicolle, L. E., Louie, T. J., Dubois, J., Martel, A., Harding, G. K. and Sinave, C. P.: Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother, 38: 1368, 1994
5. Gupta, K., Scholes, D. and Stamm, W. E.: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA, 281: 736, 1999
6. Gupta, K., Sahm, D. F., Mayfield, D. and Stamm, W. E.: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis, 33: 89, 2001
7. Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M. et al: Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis, 34: 1165, 2002
8. Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A. et al: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA, 283: 1583, 2000
9. Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J. and Stamm, W. E.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis, 29: 745, 1999
10. Henry, D. C., Jr., Bettis, R. B., Riffer, E., Haverstock, D. C., Kowalsky, S. F., Manning, K. et al: Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther, 24: 2088, 2002
11. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. National Committee for Clinical Laboratory Standards, Document M7-A5. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 2000
12. Breslow, N. E. and Day, N. E.: Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ, 32: 5, 1980
13. Cox, C. E., Marbury, T. C., Pittman, W. G., Brown, G. L., Auerbach, S. M., Fox, B. C. et al: A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. Clin Ther, 24: 223, 2002
14. Naber, K. G., di Silverio, F., Geddes, A. and Guibert, J.: Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J Antimicrob Chemother, suppl., 37: 135, 1996
15. Harding, G., Nicolle, L., Wenman, W., Richards, G., Louie, T., Martel, A. et al: Randomised comparison of oral ciprofloxacin vs standard parenteral therapy in the treatment of complicated urinary tract infections. Drugs, suppl., 45: 333, 1993
16. Cox, C. E.: A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. Am J Med, 92: 82S, 1992
17. Fang, G. D., Brennen, C., Wagener, M., Swanson, D., Hilf, M., Zadecky, L. et al: Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. Antimicrob Agents Chemother, 35: 1849, 1991
18. Mombelli, G., Pezzoli, R., Pinoja-Lutz, G., Monotti, R., Marone, C. and Franciolli, M.: Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med, 159: 53, 1999
19. Ronald, A. R. and Harding, G. K.: Complicated urinary tract infections. Infect Dis Clin North Am, 11: 583, 1997
20. Mazzulli, T.: Resistance trends in urinary tract pathogens and impact on management. J Urol, 168: 1720, 2002